Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Pathway Therapeutics raises funds for PI3K inhibitor development

Aug. 12, 2010

Epitherix identifies novel chemical scaffolds targeting Wnt pathway

Aug. 12, 2010

New models predict activity/selectivity of cannabinoid receptor agonists/antagonists

Aug. 11, 2010

Vectura and GSK sign license agreement for dry powder drug formulations

Aug. 10, 2010

Impax Laboratories and Perrigo collaborate on topical drug products

Aug. 9, 2010

MannKind discloses new agents for pulmonary drug delivery

Aug. 9, 2010

Seattle Genetics and Genentech expand antibody-drug conjugate agreement

Aug. 4, 2010

Harvard College claims new fluorinated compounds

Aug. 2, 2010

Marina Biotech and University of Helsinki extend collaboration

July 28, 2010

Astellas extends license of Regeneron's VelocImmune technology

July 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...